Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA)

Q: What does CUSIP 87990A106 represent in this 13F holders report?

CUSIP 87990A106 is the security identifier for TNYA - Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held TNYA - Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share in Q2 2024?

94 institutional investors reported TNYA - Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share for Q2 2024. Use the holders table for investor-level position and value details.

CUSIP: 87990A106

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 213,832,909
Total 13F shares: 57,076,933
Share change: +1,000,997
Total reported value: $176,981,415
Put/Call ratio: 2%
Price per share: $3.10
Number of holders: 94
Value change: +$2,253,617
Number of buys: 52
Number of sells: 40

Quarterly Holders Quick Answers

What is CUSIP 87990A106?
CUSIP 87990A106 identifies TNYA - Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2024
Previous quarter: Q1 2024

Recent filing periods for CUSIP 87990A106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TNYA - Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Column Group LLC	13F	Company	4.4%	9,400,290	$49,163,517	—	31 Mar 2024	13F
Casdin Capital, LLC	13F	Company	3.1%	6,732,971	$35,213,438	—	31 Mar 2024	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	2.7%	5,755,050	$30,098,912	—	31 Mar 2024	13F
Eli Casdin	3/4/5	Director	— mixed-class rows	7,472,698 mixed-class rows	$25,895,944	—	17 Nov 2022	3/4/5
BlackRock Finance, Inc.	13F	Company	2.2%	4,700,997	$24,586,215	—	31 Mar 2024	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.6%	3,346,522	$17,503,000	—	31 Mar 2024	13F
FMR LLC	13F	Company	1.4%	2,910,126	$15,219,959	—	31 Mar 2024	13F
VANGUARD GROUP INC	13F	Company	1.3%	2,862,916	$14,973,050	—	31 Mar 2024	13F
Octagon Capital Advisors LP	13F	Company	1.3%	2,854,000	$14,926,420	—	31 Mar 2024	13F
Integral Health Asset Management, LLC	13F	Company	1.1%	2,250,000	$11,767,500	—	31 Mar 2024	13F
CITADEL ADVISORS LLC	13F	Company	1.1%	2,247,516	$11,754,508	—	31 Mar 2024	13F
VR Adviser, LLC	13F	Company	0.73%	1,555,556	$8,135,558	—	31 Mar 2024	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.49%	1,040,046	$5,440,017	—	31 Mar 2024	13F
Euclidean Capital LLC	13F	Company	0.47%	1,015,705	$5,312,137	—	31 Mar 2024	13F
STATE STREET CORP	13F	Company	0.45%	969,297	$5,069,423	—	31 Mar 2024	13F
Alphabet Inc.	13F	Company	0.43%	915,705	$4,789,137	—	31 Mar 2024	13F
Ghost Tree Capital, LLC	13F	Company	0.36%	775,000	$4,053,250	—	31 Mar 2024	13F
StepStone Group LP	13F	Company	0.22%	462,163	$2,417,113	—	31 Mar 2024	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.19%	400,000	$2,092,000	—	31 Mar 2024	13F
NORTHERN TRUST CORP	13F	Company	0.19%	397,661	$2,079,767	—	31 Mar 2024	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.18%	375,102	$1,961,783	—	31 Mar 2024	13F
Timothy Hoey	3/4/5	Chief Scientific Officer	— mixed-class rows	320,346 mixed-class rows	$1,717,496	—	05 Mar 2024	3/4/5
MORGAN STANLEY	13F	Company	0.15%	315,889	$1,652,099	—	31 Mar 2024	13F
Casdin Partners Master Fund, L.P.	3/4/5	10%+ Owner	— class O/S missing	361,969	$1,541,988	—	03 Aug 2021	3/4/5
Nuveen Asset Management, LLC	13F	Company	0.13%	286,805	$1,499,990	—	31 Mar 2024	13F
BARCLAYS PLC	13F	Company	0.13%	274,013	$1,433,088	—	31 Mar 2024	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.11%	225,869	$1,181,296	—	31 Mar 2024	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.1%	224,051	$1,172,000	—	31 Mar 2024	13F
PFM Health Sciences, LP	13F	Company	0.1%	222,222	$1,162,221	—	31 Mar 2024	13F
Bank of New York Mellon Corp	13F	Company	0.1%	211,494	$1,106,114	—	31 Mar 2024	13F
BIT Capital GmbH	13F	Company	0.09%	200,668	$1,049,494	—	31 Mar 2024	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.09%	193,221	$1,010,546	—	31 Mar 2024	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.09%	193,000	$1,009,390	—	31 Mar 2024	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.09%	190,000	$993,700	—	31 Mar 2024	13F
NEOS Investment Management LLC	13F	Company	0.09%	183,420	$959,287	—	31 Mar 2024	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.08%	179,132	$936,000	—	31 Mar 2024	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.08%	168,565	$881,595	—	31 Mar 2024	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.06%	128,120	$670,068	—	31 Mar 2024	13F
Qube Research & Technologies Ltd	13F	Company	0.06%	127,232	$665,423	—	31 Mar 2024	13F
Soleus Capital Management, L.P.	13F	Company	0.06%	122,222	$639,221	—	31 Mar 2024	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.05%	114,700	$599,881	—	31 Mar 2024	13F
Leone D. Patterson	3/4/5	Chief Fin. and Bus. Officer	— mixed-class rows	300,755 mixed-class rows	$590,330	—	23 Feb 2024	3/4/5
UBS Group AG	13F	Company	0.05%	110,176	$576,220	—	31 Mar 2024	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.05%	108,345	$566,644	—	31 Mar 2024	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.04%	82,112	$429,446	—	31 Mar 2024	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.04%	79,968	$418,233	—	31 Mar 2024	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.03%	71,580	$374,364	—	31 Mar 2024	13F
RHUMBLINE ADVISERS	13F	Company	0.03%	70,719	$369,852	—	31 Mar 2024	13F
Squarepoint Ops LLC	13F	Company	0.03%	64,888	$339,364	—	31 Mar 2024	13F
CORNERCAP INVESTMENT COUNSEL INC	13F	Company	0.03%	64,563	$337,664	—	31 Mar 2024	13F

Institutional Holders of Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA) as of Q2 2024

As of 30 Jun 2024, Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA) was held by 94 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 57,076,933 shares. The largest 10 holders included Column Group LLC, RA CAPITAL MANAGEMENT, L.P., Casdin Capital, LLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Octagon Capital Advisors LP, Integral Health Asset Management, LLC, CITADEL ADVISORS LLC, and VR Adviser, LLC. This page lists 94 institutional shareholders reporting positions in this security for the Q2 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Q2 2024 holders

Holder diff

Investor	Q1 2024 Shares	Q2 2024 Shares	Share Diff	Share Chg %	Q1 2024 Value $	Q2 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.